Hoffman-La Roche Ltd. v. Apotex Inc. et al., (2013) 436 F.T.R. 198 (FC)

This document cites

• F.H. v. McDougall, (2008) 260 B.C.A.C. 74 (SCC)
• Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
• Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 440 N.R. 269 (FCA)
• Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 414 F.T.R. 56 (FC)
• Dimplex North America Ltd. v. CFM Corp., 2006 FC 586



See all quotations

• Biovail Pharmaceuticals Inc. et al. v. Canada (Minister of National Health and Welfare) et al., 2005 FC 9
• Ruddell v. BC Rail Ltd., (2007) 381 N.R. 399 (Motion)
• Eli Lilly Canada Inc. v. Apotex Inc. et al., (2008) 323 F.T.R. 56 (FC)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2007) 366 N.R. 347 (FCA)
• Rothmans, Benson & Hedges Inc. et al. v. Imperial Tobacco Ltd., (1993) 152 N.R. 292 (FCA)
• Laboratoires Servier et al. v. Apotex Inc. et al., (2008) 332 F.T.R. 193 (FC)
• Abbott Laboratories et al. v. Canada (Minister of Health) et al., 2009 FCA 94
• Free World Trust v. Électro Santé Inc. et al., (2000) 263 N.R. 150 (SCC)
• Beloit Canada Ltd. v. Valmet Oy, (1986) 64 N.R. 287 (FCA)
• GlaxoSmithKline Inc. et al. v. Pharmascience Inc. et al., 2008 FC 593
• Dimplex North America Ltd. v. CFM Corp., 2007 FCA 278
• Pfizer Can. Inc. v. Novopharm, 2005 FCA 270
• GlaxoSmithKline Inc. et al. v. Pharmascience Inc. et al., (2011) 385 F.T.R. 157 (FC)
• Merck & Co. et al. v. Canada (Minister of Health) et al., 2010 FC 1042
• Shire Biochem Inc. et al. v. Canada (Minister of Health) et al., (2008) 328 F.T.R. 123 (FC)
• Pfizer Canada Inc. et al. v. Pharmascience Inc. et al., (2013) 427 F.T.R. 6 (FC)
• AstraZeneca Canada Inc. et al. v. Teva Canada Ltd. et al., (2013) 428 F.T.R. 269 (FC)
• Schering-Plough Canada Inc. et al. v. Pharmascience Inc. et al., 2009 FC 1128
• Pfizer Canada Inc. et al. v. ratiopharm Inc. et al., 2010 FC 612
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., 2007 FC 26
• BESTE v. Can. (A.G.), [2007] N.R. Uned. 201 (FCA)
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., (2004) 329 N.R. 152 (FCA)
• Laboratoires Servier et al. v. Apotex Inc. et al., (2009) 392 N.R. 96 (FCA)
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., (2004) 245 F.T.R. 243 (FC)
• Lundbeck Canada Inc. v. Canada (Minister of Health) et al., 2010 FCA 320
• AstraZeneca Canada Inc. et al. v. Apotex Inc. et al., 2010 FC 714
• Abbott Laboratories et al. v. Canada (Minister of Health) et al., (2007) 361 N.R. 308 (FCA)
• Lundbeck Canada Inc. v. Canada (Minister of Health) et al., (2009) 343 F.T.R. 53 (FC)
• Abbott Laboratories et al. v. Canada (Minister of Health) et al., 2008 FC 1359
• Apotex Inc. v. Sanofi-Aventis, (2011) 402 F.T.R. 1 (FC)